rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
11 Suppl 4
|
pubmed:dateCreated |
2008-5-23
|
pubmed:abstractText |
The results of clinical trials that led to modern first- and second-line chemotherapeutic regimens for metastatic colorectal cancer, including studies of recently introduced monoclonal antibody products that target vascular endothelial growth factor (VEGF) and epidermal growth factor receptor (EGFR), are described, as well as new therapeutic targets being studied and challenges in research to identify and evaluate new therapies.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Angiogenesis Inhibitors,
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal,
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, Humanized,
http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Camptothecin,
http://linkedlifedata.com/resource/pubmed/chemical/Organoplatinum Compounds,
http://linkedlifedata.com/resource/pubmed/chemical/Receptor, Epidermal Growth Factor,
http://linkedlifedata.com/resource/pubmed/chemical/bevacizumab,
http://linkedlifedata.com/resource/pubmed/chemical/irinotecan,
http://linkedlifedata.com/resource/pubmed/chemical/oxaliplatin
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
1535-2900
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:day |
1
|
pubmed:volume |
65
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
S15-21; quiz S22-4
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:18499885-Angiogenesis Inhibitors,
pubmed-meshheading:18499885-Antibodies, Monoclonal,
pubmed-meshheading:18499885-Antibodies, Monoclonal, Humanized,
pubmed-meshheading:18499885-Antineoplastic Agents,
pubmed-meshheading:18499885-Antineoplastic Protocols,
pubmed-meshheading:18499885-Camptothecin,
pubmed-meshheading:18499885-Clinical Trials as Topic,
pubmed-meshheading:18499885-Colorectal Neoplasms,
pubmed-meshheading:18499885-Humans,
pubmed-meshheading:18499885-Neoplasm Metastasis,
pubmed-meshheading:18499885-Organoplatinum Compounds,
pubmed-meshheading:18499885-Receptor, Epidermal Growth Factor
|
pubmed:year |
2008
|
pubmed:articleTitle |
Current and emerging therapies for metastatic colorectal cancer: applying research findings to clinical practice.
|
pubmed:affiliation |
University of California Los Angeles (UCLA) Gastrointestinal Oncology Program, David Geffen School of Medicine at UCLA, 10945 Le Conte Avenue, Los Angeles, CA, USA. jrhecht@mednet.ucla.edu
|
pubmed:publicationType |
Journal Article
|